ICD-10-CM › D50-D89 › D70-D77 › D70 Neutropenia › D70.1

D70.1

Agranulocytosis secondary to cancer chemotherapy

ValidICD-10-CM diagnosis code.

Valid for claims with a date of service in the current code year.

Valid FY2016 onwards.

What has happened to this code

Every change the publisher made, from 2007 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.

  1. FY2007 Added to the draft code set draft Agranulocytosis secondary to cancer chemotherapy

Official coding rules

Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.

Inherited from D70 Neutropenia

Excludes1 - never coded here

  • neutropenic splenomegaly (D73.81)
  • transient neonatal neutropenia (P61.5)

Use additional code

  • code for any associated:
  • fever (R50.81)

Code also

  • , if applicable, mucositis (J34.81, K12.3-, K92.81, N76.81)

Includes

  • agranulocytosis
  • decreased absolute neurophile count (ANC)

How CDC's index refers to this code

Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.

Showing 40 of 49 index phrases.

Codes in the same group

CodeDescriptionStatus
D70.0 Congenital agranulocytosis Valid
D70.2 Other drug-induced agranulocytosis Valid
D70.3 Neutropenia due to infection Valid
D70.4 Cyclic neutropenia Valid
D70.8 Other neutropenia Valid
D70.9 Neutropenia, unspecified Valid